U. Kaul et al., Percutaneous transluminal myocardial revascularization with a holmium laser system: Procedural results and early clinical outcome, CATHET C IN, 47(3), 1999, pp. 287-291
Surgical transmyocardial laser revascularization has been reported to impro
ve clinical outcome in patients with refractory angina who are not candidat
es for angioplasty or bypass surgery. We investigated the feasibility and s
afety of a nonsurgical, percutaneous technique for laser channel creation u
sing energy from a holmium:yttrium-aluminium-garnet (YAG) laser. The laser
energy was directed through a fiber enclosed in a catheter to the ventricul
ar myocardium creating channels between the blood pool and the myocardium,
Thirty-five patients with angina and coronary anatomy not amenable to revas
cularization with coronary angioplasty or bypass surgery underwent percutan
eous transluminal myocardial revascularization. A total of 15 +/- 5 channel
s were formed per patient, There was no procedure-related mortality. One pa
tient developed cardiac tamponade requiring thoracotomy and another a minor
self-limiting pericardial effusion. There was no worsening of regional wal
l motion function in any patient. All patients were discharged alive after
a postprocedure hospital stay of 2.1 +/- 1.4 days. Mean Canadian Cardiovasc
ular Society (CCS) functional class declined from 3.68 +/- 0.4 before proce
dure to 0.82 +/- 0.7 at 30 days (P < 0.01). At 3 months, mean angina class
was 0.94 +/- 0.65 (n = 35; P < 0.01) and at 6 months, mean angina class was
1.08 +/- 0.58 (n = 26; P < 0.01). One patient required repeat revasculariz
ation after 5 months for progression of disease in a degenerated saphenous
venous graft supplying different region of myocardium. We conclude that tra
nsmyocardial revascularization using holmium:YAG laser by percutaneous tech
nique can be carried out safely with encouraging early results and a very l
ow complication rate, The symptomatic relief seen up to 6 months has been e
xcellent. The long-term effects of this technique on mortality and relief o
f angina, however, remain to be defined. Cathet. Cardiovasc, Intervent, 47:
287-291, 1999, (C) 1999 Wiley-Liss, Inc.